spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 4


Fig. 4. IRSp53 exists in a complex with WAVE2 and Abi1 in a Rac1-dependent manner. (A) Lysates from nontransfected or GFP-tagged IRSp53 and Myc-tagged Rac1- or Rac1N17- or Rac1Q61L- or Cdc42V12-coexpressing RAW/LR5 cells and Cos7 cells were immunoprecipitated with antibodies against either GFP or Myc (IP) and subjected to western blotting using the indicated antibodies. A representative example of three independent experiments is shown. (B) Lysates from mock- or IRSp53-shRNA-treated RAW/LR5 cells expressing Myc-tagged Rac1Q61L were immunoprecipitated with antibodies against Myc (IP) and were then subjected to western blotting using the indicated antibodies. (C) Quantification of WAVE2 or Abi1 co-immunoprecipitated by Myc (from B) is shown; n=3; *, P<0.05 compared with mock-shRNA-treated cells expressing Rac1Q61L. (D) Lysates from nontransfected or Myc-tagged Rac1Q61L- and HA-tagged IRSp53{Delta}SH3-coexpressing RAW/LR5 cells were incubated with antibodies against HA for immunoprecipitation (IP-HA), followed by sequential immunoprecipitation of Rac1Q61L using antibodies against Myc (IP-Myc). Immunoprecipitates were then subjected to western blotting using the indicated antibodies. Mock- or IRSp53-shRNA-treated (E) or WAVE2-shRNA-treated (F) RAW/LR5 cells either transiently transfected with the indicated constructs, or not, were stimulated with CSF-1 and their ability to form F-actin-rich protrusions in response to CSF-1 was analyzed as in Fig. 2D and expressed as a percentage of the CSF-1 stimulation observed in nontransfected mock-shRNA-treated cells; n=3; *, P<0.05 compared with nontransfected mock-shRNA-treated cells (represented by the dotted line).





Right arrow Return to article